GB1539510A - Injectable compositions - Google Patents

Injectable compositions

Info

Publication number
GB1539510A
GB1539510A GB35113/75A GB3511375A GB1539510A GB 1539510 A GB1539510 A GB 1539510A GB 35113/75 A GB35113/75 A GB 35113/75A GB 3511375 A GB3511375 A GB 3511375A GB 1539510 A GB1539510 A GB 1539510A
Authority
GB
United Kingdom
Prior art keywords
injectable compositions
injectable
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB35113/75A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB35113/75A priority Critical patent/GB1539510A/en
Publication of GB1539510A publication Critical patent/GB1539510A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
GB35113/75A 1976-08-23 1976-08-23 Injectable compositions Expired GB1539510A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB35113/75A GB1539510A (en) 1976-08-23 1976-08-23 Injectable compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB35113/75A GB1539510A (en) 1976-08-23 1976-08-23 Injectable compositions

Publications (1)

Publication Number Publication Date
GB1539510A true GB1539510A (en) 1979-01-31

Family

ID=10373973

Family Applications (1)

Application Number Title Priority Date Filing Date
GB35113/75A Expired GB1539510A (en) 1976-08-23 1976-08-23 Injectable compositions

Country Status (1)

Country Link
GB (1) GB1539510A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2469179A1 (en) * 1979-11-08 1981-05-22 Beecham Group Ltd PHARMACEUTICAL COMPOSITION FOR INJECTION CONTAINING A PENICILLIN
EP0278243A1 (en) * 1987-01-14 1988-08-17 Tanabe Seiyaku Co., Ltd. Medical preparation comprising aspoxicillin, a method for its preparation, and the use of such a preparation for the manufacture of a medicament

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2469179A1 (en) * 1979-11-08 1981-05-22 Beecham Group Ltd PHARMACEUTICAL COMPOSITION FOR INJECTION CONTAINING A PENICILLIN
EP0029668A1 (en) * 1979-11-08 1981-06-03 Beecham Group Plc Pharmaceutical injectable composition and two-pack container for said composition
EP0278243A1 (en) * 1987-01-14 1988-08-17 Tanabe Seiyaku Co., Ltd. Medical preparation comprising aspoxicillin, a method for its preparation, and the use of such a preparation for the manufacture of a medicament
US4966899A (en) * 1987-01-14 1990-10-30 Tanabe Seiyaku Co., Ltd. Antibacterial lyophilized preparation of aspoxicillin

Similar Documents

Publication Publication Date Title
JPS5285123A (en) Fluorocarbonsiloxane compositions
JPS5326331A (en) Decayeddtooth preventing composition
JPS5359016A (en) Pharmatoceutical composition
JPS5569631A (en) Fireeretarded additive composition
JPS5316787A (en) Specificcreactive composition
AU2732277A (en) Soil-hardening composition
GB1537725A (en) Asphalt compositions
JPS5356325A (en) Composition having antiicoagulation effect
JPS5355360A (en) Heattactivating composition
JPS52128946A (en) Compositions
JPS52143827A (en) Improved lighttsensitive composition
JPS52117437A (en) Antiicoccidium composition
JPS5371075A (en) Compositions
ZA777609B (en) Novel synergistic compositions
ZA773013B (en) Anti-odorant compositions
JPS5293405A (en) Additive composition
GB1547106A (en) Grightening compositions
JPS5354593A (en) Solid compositions
GB1551637A (en) Hygieniccosmetic compositions
JPS5341436A (en) Antiiparasite composition
JPS52142752A (en) Moistureeresistant composition
IL51365A0 (en) Coccidiocidal composition
IE44735L (en) Fibrinogenase composition
PH12752A (en) Injectable metromidazole composition
IL51791A0 (en) New injectable medicinal compositions

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee